Aim. To study the socio-demographic and clinical profile of patients s
eeking treatment for abuse of codeine-containing cough syrups (CCS). D
esign. Observational; case series. Setting. An addiction clinic in Nor
th India. Participants. Forty-six consecutive treatment-seeking patien
ts of DSM-III-R-diagnosed dependence on CCS, from January 1994 to June
1995. Measurements. Semi-structured interview schedule for patients a
nd their family covering socio-demographic and clinical variables. Fin
dings. All patients were male. Many were young (mean age 27 years), wi
th completed school education (85%) and from urban backgrounds (80%).
The mean age of starting CCS use was 23 years. Initiated commonly thro
ugh friends (89%) and often for curiosity (63%), 89% of the patients p
rogressed to daily use of CCS in less than 6 months (54% in less than
a month), and in quantities much higher than prescribed limits. Opioid
-like withdrawal was reported by 92%. Concurrent use of other substanc
es, psychiatric co-morbidity and HIV-related risk behaviour were prese
nt in 72%, 24% and 45%, respectively. Most of the patients reported a
'stimulant' effect of CCS ('alert', 96%; 'more active: 94%). Conclusio
ns. The combination of an opioid and a sympathomimetic agent in the CC
S may cause a special, distinct euphoretic effect. This effect, along
with the low price, easy availability and 'pure' preparation of CCS, m
ay be responsible for the rapidly rising popularity of the CCS as drug
s of abuse in India.